Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CanSino Biologics Inc.
  6. News
  7. Press Releases
    6185   CNE100003F01

CANSINO BIOLOGICS INC.

(6185)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société CANSINO BIOLOGICS INC.
09/06CORONAVIRUS PANDEMIC : Chinese developer shares efficacy of inhaled vaccines
PU
07/29CANSINO BIOLOGICS : Announcement change of venue of the 2021 first extraordinary general m..
PU
06/23CANSINO BIOLOGICS : CanSinoBIO Announces Approval for Its Group A and Group C Meningococca..
PU
05/24CANSINO BIOLOGICS : CanSinoBIO Receives European GMP Certification for its COVID-19 Vaccin..
AQ
05/22CANSINO BIOLOGICS : CanSinoBIO Receives EU GMP Certificate
PU
05/17CANSINO BIOLOGICS : Discloseable transaction purchase of structured deposits
PU
05/12CANSINO BIOLOGICS : Supplemental Form of Proxy for use at the 2020 Annual General Meeting ..
PU
05/12CANSINO BIOLOGICS : Supplemental notice of 2020 annual general meeting
PU
05/12CANSINO BIOLOGICS : Supplemental circular proposed change in use of proceeds from a share ..
PU
04/29CANSINO BIOLOGICS : Proposed change in use of proceeds from a share offering
PU
04/29CANSINO BIOLOGICS : First quarterly report for the three months ended march 31, 2021
PU
04/19CANSINO BIOLOGICS : 2020 agm circular
PU
04/19CANSINO BIOLOGICS : Form of Proxy for use at the 2020 Annual General Meeting to be held on..
PU
04/14CANSINO BIOLOGICS : Voluntary announcement
PU
04/13CANSINO BIOLOGICS : Voluntary announcement - enrollment of phase iii clinical trial for 13..
PU
04/08CANSINO BIOLOGICS : CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Con..
AQ
04/08CANSINO BIOLOGICS : Inside information recombinant novel coronavirus vaccine (adenovirus t..
PU
03/28CANSINO BIOLOGICS : (1) proposed change of a supervisor and (2) proposed change of auditor..
PU
03/26CANSINO BIOLOGICS : Annual results announcement for the year ended december 31, 2020 closu..
PU
03/22CANSINO BIOLOGICS : Inside information national medical products administration's approval..
PU
03/22CANSINO BIOLOGICS : CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Con..
AQ
03/22CANSINO BIOLOGICS : Hungary approves 2 more vaccines from outside EU amid spike
AQ
03/21CANSINO BIOLOGICS : Inside information recombinant novel coronavirus vaccine (adenovirus t..
PU
03/11CHINESE GOVERNMENT INTERFERENCE DERA : researcher
AQ
02/27CANSINO BIOLOGICS : CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine in ..
PU
02/25CANSINO BIOLOGICS : Inside information nmpa's grant of conditional marketing authorization..
PU
02/25CANSINO BIOLOGICS : Inside information updates on 2020 preliminary annual results
PU
02/24CANSINO BIOLOGICS : NMPA Accepts the Application for Conditional Marketing Authorization o..
PU
02/23CANSINO BIOLOGICS : Inside information nmpa's acceptence of application for conditional ma..
PU
2020CANSINO BIOLOGICS : Notice of the 2020 first extraordinary general meeting
PU
2020CANSINO BIOLOGICS : (1) change in use of the remaining unutilized proceeds received from t..
PU
2020CANSINO BIOLOGICS : Form of Proxy for use at the 2020 First Extraordinary General Meeting ..
PU
2020CANSINO BIOLOGICS : Canada-China COVID-19 vaccine trials abandoned amid political tensions
AQ
2020CANSINO BIOLOGICS : Closure of register of members
PU
2020CANSINO BIOLOGICS : Change in accounting policy
PU
2020CANSINO BIOLOGICS : Proposed change in use of proceeds from the listing
PU
2020CANSINO BIOLOGICS : CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Du..
PR
2020CANSINO BIOLOGICS : Terms of reference for the remuneration and assessment committee of th..
PU
2020CANSINO BIOLOGICS : Terms of reference for the nomination committee of the board
PU
2020CANSINO BIOLOGICS : Terms of reference of the audit committee of the board
PU
2020CANSINO BIOLOGICS : Articles of association
PU
2020CANSINO BIOLOGICS : Inside information completion of the issue of a shares
PU
2020CANSINO BIOLOGICS : Inside information determination of the offer size and issue price for..
PU
2020CANSINO BIOLOGICS : Inside information cooperation with pfizer to promote mcv4 product men..
PU
2020CANSINO BIOLOGICS : Inside information preliminary price consultation period of proposed i..
PU
2020CANSINO BIOLOGICS : COVID-19 vaccine generates immune response in 90% of patients
AQ
2020COVID-19 : CanSino's vaccine gets approval for military use in China
AQ
2020CANSINO BIOLOGICS : and Precision NanoSystems Announce Collaboration to Co-Develop a COVID..
AQ
2020COVID-19 : Cross Country Update (May 12, 2020)
AQ
2020Hope as race for Coronavirus vaccine hots up
AQ
2020CANSINO BIOLOGICS : Nationalism trumps cooperation in virus vaccine race
AQ
2020CANSINO BIOLOGICS : China announces first human trials of Covid-19 vaccine
AQ
2020CANSINO BIOLOGICS : Inside information development of covid-19 vaccine candidate
PU
2020CANSINO BIOLOGICS : An announcement has just been published by the issuer in the Chinese s..
PU
2020CANSINO BIOLOGICS : Inside information financial information in relation to a share prospe..
PU
2019CANSINO BIOLOGICS : Voluntary announcement - center for drug evaluation granted priority r..
PU
2019CANSINO BIOLOGICS : Poll results of the 2019 first extraordinary general meeting, the 2019..
PU
2019CANSINO BIOLOGICS : Voluntary announcement - national medical products administration acce..
PU
2019CANSINO BIOLOGICS : Reply Slip for the 2019 First Class Meeting of Domestic Shareholders a..
PU
2019CANSINO BIOLOGICS : Form of Proxy for use at the 2019 First Class Meeting of Domestic Shar..
PU
2019CANSINO BIOLOGICS : Notice of the 2019 first class meeting of domestic shareholders and un..
PU
2019CANSINO BIOLOGICS : Reply Slip for the 2019 First Class Meeting of H Shareholders to be he..
PU
2019CANSINO BIOLOGICS : Form of Proxy for use at the 2019 First Class Meeting of H Shareholder..
PU
2019CANSINO BIOLOGICS : Notice of the 2019 first class meeting of h shareholders
PU
2019CANSINO BIOLOGICS : Reply Slip for the 2019 First Extraordinary General Meeting to be held..
PU
2019CANSINO BIOLOGICS : Form of Proxy for use at the 2019 First Extraordinary General Meeting ..
PU
2019CANSINO BIOLOGICS : Notice of the 2019 first extraordinary general meeting
PU
2019CANSINO BIOLOGICS : (1) proposed issue of a shares and listing on the sse star market and ..
PU
2019CANSINO BIOLOGICS : Proposed issue of a shares and listing on the sse star market and othe..
PU